No Data
Xiamen Kingdomway Group (002626.SZ): received 1 invention patent certificate
Gelonghui November 7th | Xiamen Kingdomway Group (002626.SZ) announced that its controlling subsidiary, Jiangsu Chengxin Pharmaceutical Co., Ltd., and its wholly-owned subsidiary, Xiamen Kingdomway Biotechnology (Jiangsu) Co., Ltd., recently received a patent certificate issued by the National Intellectual Property Office for an invention named a method for preparing L-carnosine zinc complex. This invention provides a method for preparing L-carnosine zinc complex. In the complexation reaction stage of the preparation method, water is not required, using a water-free solvent system, reducing the purification difficulty of the product. After solid-liquid separation, the amount of residual solvent in the wet product is small, reducing the difficulty of subsequent granulation.
Kim Dawei: Third quarter report 2024
xiamen kingdomway group (002626.SZ) released the performance for the first three quarters, with a net income of 0.221 billion yuan, a year-on-year decrease of 9.35%.
Xiamen Kingdomway Group (002626.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenues of 2...
Concept Mining | A major breakthrough in the "longevity drug", will concept stocks usher in a period of outbreak?
Increase by 100 times.
Express News | Macrobiotic nmn concept strengthens, xiamen kingdomway group hits limit up.
Express News | NMN concept stocks opened actively, aba chemicals corporation opened more than 13% higher.
No Data
No Data